Responding to an FDA Warning — Geographic Variation in the Use of Rosiglitazone — NEJM

Tweet

Responding to an FDA Warning — Geographic Variation in the Use of Rosiglitazone — NEJM A good article showing how crazy USA healthcare drug regulation can be. A drug which is banned in Europe now, yet can still be prescribed in USA. There is a clear increased risk of cardiovascular disease in diabetes mellitus patients taking this drug.

If you know a relative or friend who is still taking rosiglitazone, please, please get them to see their doctor to change to an alternative (e.g. pioglitazone) or a different agent altogether.

Doing this may save a life or two, and reduce healthcare costs overall!

obnoxious librarian from hades

Tweet

obnoxious librarian from hades Dilbert like humour from, of all places, a library!

Tricyclics Lighten Headache Burden in Patients with Migraine and Tension Headaches - General Medicine

Tweet

Tricyclics Lighten Headache Burden in Patients with Migraine and Tension Headaches - General Medicine Fits in with current thinking

Vitamin D Deficiency Linked to Fatal Stroke in Whites But Not Blacks

Tweet

Vitamin D Deficiency Linked to Fatal Stroke in Whites But Not Blacks .

A timely reminder that vitamin D levels are important, folks

Home is where the heart(h) is...

Tweet

Follow Prof Chris Dowrick at his blog page - primhe Mental wellbeing guru.

And also check out www.livinglifetothefull.com

The armchair kitchen

Tweet

The armchair kitchen what a treasure trove of foodie things!

FDA approves Pradaxa to prevent stroke in people with atrial fibrillation

Tweet

FDA approves Pradaxa to prevent stroke in people with atrial fibrillation may spell the death knell for the upiquitous INR/anticoagulation clinics. If not pradaxa, perhaps a future agent. The hidden costs of transport, staffing, interpretation, and informing patients which are generated by INR clinics may be a good reason to encourage drugs like pradaxa. In the 21st century, INR clinics are an anachronism, IMHO.